Post-treatment immunomodulation & neuro-muscular repair support
Stem cell therapy for Lyme disease in Istanbul, Turkey
Our Istanbul medical team led by Uzm. Dr. Cihan Bolat evaluates your post-treatment Lyme history, inflammatory markers, and symptoms to design an individualized Wharton's jelly MSC and exosome protocol.
Condition-specific editorial anatomy. Explanatory labels remain in accessible text.
Understanding the condition
Understanding the condition and our regenerative approach
Many individuals who have completed standard antibiotic courses for Lyme disease continue to struggle with debilitating post-treatment symptoms — including crushing physical fatigue, migratory joint and tendon pain, peripheral nerve tingling or burning, autonomic instability, and persistent cognitive fog. Even after Borrelia bacteria have been addressed by antimicrobial therapy, the immune system can remain locked in a state of post-infectious dysregulation, pouring out inflammatory cytokines and reactive oxygen species that keep synovial joints, peripheral nerves, and neuro-glial networks under constant biological stress.
Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) and WJ-MSC-derived exosomes are investigated in post-treatment Lyme syndrome for their capacity to reset this hyperactive immune response and support cellular repair across stressed neuro-muscular tissues. Administered systemically, WJ-MSCs release immunomodulatory mediators (IL-10, PGE2, TGF-beta modulators) that quiet persistent TNF-alpha, IL-6, and interferon-gamma cascades, shift pro-inflammatory M1 macrophages and microglia toward reparative M2 phenotypes, and restore FoxP3+ regulatory T-cell (Treg) balance. Simultaneously, nanoscale WJ-MSC exosomes cross biological barriers to deliver neurotrophic growth factors (BDNF, NGF, GDNF), angiogenic VEGF, and regulatory microRNAs directly to irritated peripheral nerves, synovial membranes, and cellular mitochondria — helping calm neuro-inflammation, repair myelin and axonal homeostasis, and restore cellular energy production.
At our Istanbul clinic, Uzm. Dr. Cihan Bolat and our medical team verify your prior diagnostic serology and completed antibiotic history, review your current inflammatory and neurological records, and design a personalized WJ-MSC and exosome protocol. Our goal is to help quiet post-infectious immune reactivity, ease joint and nerve discomfort, clear cognitive fog, and support lasting physical stamina.
Reviewed by: Uzm. Dr. Cihan Bolat · Reviewed · Re-review due
What happens inside the body
Key biological processes and therapeutic targets
Even after Borrelia infection is addressed by standard antimicrobial therapy, persistent immune dysregulation and neuro-glial inflammation can continue to strain joints, nerves, and cellular energy. Regenerative medicine targets these post-infectious pathways to help restore tissue homeostasis.
What our protocol aims to support
- Resetting post-infectious immune balance: Supporting regulatory T-cell (Treg) pathways and M1-to-M2 macrophage polarization to help quiet chronic post-infectious cytokine cascades.
- Supporting peripheral nerve & cognitive comfort: Delivering neurotrophic paracrine factors and exosomal microRNAs aimed at calming neuro-inflammatory signaling and supporting clearer cognitive stamina.
- Easing joint, tendon & muscular stiffness: Providing systemic anti-inflammatory and trophic support to help improve joint comfort, physical endurance, and post-exertional recovery.
- Complementing your home physician's care after antibiotic completion: Because stem cells and exosomes are immunomodulatory biologics rather than antibiotics, our protocol is planned after your home specialist has completed any required antimicrobial therapy.
- 01
Persistent post-infectious immune dysregulation
Following exposure to Borrelia spirochetes and subsequent antimicrobial treatment, molecular mimicry and lingering antigenic debris can keep Toll-like receptors (TLRs) and adaptive T-cells in a state of chronic hypervigilance. Without adequate regulatory braking, the immune system continues attacking healthy synovial and neural microenvironments. Wharton's jelly MSCs counter this post-infectious reactivity by releasing indoleamine 2,3-dioxygenase (IDO), PGE2, and IL-10, which quiet hyperactive effector T-cells and expand FoxP3+ regulatory T-cells (Tregs). Re-establishing immune tolerance helps break the cycle of chronic post-treatment flares.
- 02
Chronic inflammatory cytokine signaling & cellular fatigue
Elevated circulating levels of IL-6, TNF-alpha, interferon-gamma, and CCL2 chemokine persist in many post-treatment Lyme patients, impairing mitochondrial oxidative phosphorylation and disrupting hypothalamic sleep and autonomic regulation. This biochemical storm manifests as profound post-exertional exhaustion, unrefreshing sleep, and orthostatic intolerance. WJ-MSCs and their exosomes transfer regulatory microRNAs (such as miR-146a and miR-21) and antioxidant enzymes that downregulate NF-kappaB signaling and protect mitochondrial bioenergetics. Lowering systemic cytokine pressure helps restore cellular ATP stamina and clearer daily vitality.
- 03
Macrophage M1 imbalance & synovial joint irritation
In antibiotic-refractory or post-infectious Lyme arthritis, synovial membranes and tendon entheses remain infiltrated by pro-inflammatory M1 macrophages and Th17 cells that secrete matrix-degrading enzymes and cause recurrent joint swelling and stiffness. Even when synovial fluid PCR is negative for active bacteria, this sterile synovitis persists. Bioactive signals from WJ-MSCs and exosomes actively reprogram synovial macrophages from destructive M1 states into reparative M2 phenotypes while delivering chondro-protective growth factors. This shift helps soothe synovial thickening, ease migratory joint aches, and restore comfortable movement.
- 04
Neuro-glial inflammation & peripheral nerve tissue stress
Post-treatment Lyme syndrome frequently involves low-grade neuro-inflammation affecting dorsal root ganglia, small-fiber peripheral nerves, and central neuro-glial networks, causing paresthesias (tingling, burning), radicular pain, and cognitive 'brain fog.' Microvascular endothelial stress further reduces oxygen delivery to these sensitive neural tissues. Nanoscale WJ-MSC exosomes cross into neural microenvironments to calm activated microglia and astrocytes while delivering BDNF, NGF, and VEGF to stressed axons and Schwann cells. Supporting neuro-vascular repair helps ease neuropathic discomfort and sharpen cognitive focus.
Why regenerative medicine is investigated
Scientific rationale for Wharton's jelly MSCs and exosomes
Calming Post-Infectious Immune Dysregulation
During Borrelia infection, the innate and adaptive immune systems mount an intense inflammatory response across joints, connective tissues, and the nervous system. In many patients, even after standard antibiotic regimens have cleared active bacterial replication, immune checkpoints fail to downshift — leaving Th1/Th17 lymphocytes, M1 macrophages, and microglia chronically activated. This lingering autoimmune-like state drives post-treatment Lyme symptoms without responding to repeated antibiotic courses. Regenerative medicine is investigated to help reset immune tolerance and calm the chronic cytokine storm at its biological source.
Neuro-Trophic & Synovial Repair via WJ-MSCs & Exosomes
Wharton's jelly-derived MSCs (WJ-MSCs) secrete potent anti-inflammatory cytokines (IL-10, TSG-6, PGE2) that convert pro-inflammatory M1 macrophages into tissue-healing M2 macrophages and expand regulatory T-cells (Tregs). Working alongside the cells, nanoscale WJ-MSC-derived exosomes circulate systemically and cross the blood-nerve and blood-brain barriers to deliver neurotrophic factors (BDNF, NGF, GDNF), antioxidant enzymes, and anti-inflammatory microRNAs. Inside stressed peripheral nerves and synovial joints, these biological signals help soothe neuro-glial inflammation, support Schwann-cell and myelin repair, and protect mitochondrial ATP energy generation.
Thorough Post-Treatment Evaluation in Istanbul
Because stem cells and exosomes are immunomodulatory and regenerative biologics rather than antimicrobials, our medical team first confirms that guideline-recommended antibiotic therapy was completed with your home physician. Uzm. Dr. Cihan Bolat then evaluates your symptom timeline, serology, CRP/ESR, neurological assessments (EMG/MRI), and co-existing autoimmune or metabolic markers. Based on this review, we tailor your GMP-certified WJ-MSC and exosome dosing and delivery routes in Istanbul, followed by structured 1, 3, and 6-month remote follow-up reviews.
Our treatment approach & administration routes
How our proposed Wharton's jelly MSC and exosome protocols work
- 01
Intravenous Wharton's Jelly MSC (WJ-MSC) Infusion
Intravenous infusion delivers high-viability, GMP-certified Wharton's jelly mesenchymal stem cells systemically to address widespread post-infectious immune dysregulation. Through paracrine secretion of IL-10, PGE2, TSG-6, and trophic growth factors, WJ-MSCs help downregulate persistent TNF-alpha, IL-6, and interferon-gamma cascades, shift macrophages from pro-inflammatory M1 to reparative M2 states, and expand regulatory T-cells (Tregs). This systemic immune recalibration helps calm sterile synovitis in aching joints, soothe perivascular inflammation, and reduce the metabolic strain driving chronic fatigue. Infusions are performed in our supervised clinical setting after confirming that prior antimicrobial therapy is complete.
Role in your protocolOur medical team determines the exact Wharton's jelly MSC and exosome combination, dosage, and administration route after evaluating your medical history and reports.
- 02
Intravenous WJ-MSC-Derived Exosome Administration
WJ-MSC-derived exosomes are nanoscale extracellular vesicles (30–150 nm) capable of crossing the blood-brain and blood-nerve barriers to reach central neuro-glial networks and peripheral nerve fibers. They carry a concentrated payload of anti-inflammatory microRNAs, neurotrophic factors (BDNF, NGF, GDNF), and mitochondrial-protective proteins directly to stressed neurons, Schwann cells, and synovial tissues. Administered alongside WJ-MSCs, exosomes provide rapid vesicular signaling to help calm neuropathic tingling, cognitive fog, and cellular oxidative stress. We note transparently that while cellular and exosomal mechanisms are complementary, whether combined MSC and exosome therapy outperforms single-modality treatment remains under clinical study.
Role in your protocolOur medical team determines the exact Wharton's jelly MSC and exosome combination, dosage, and administration route after evaluating your medical history and reports.
- 03
Intramuscular Administration (When Included in Your Protocol)
In selected post-treatment Lyme protocols, our physicians incorporate intramuscular administration to create a localized muscular depot for sustained paracrine release. Whereas intravenously infused MSCs experience initial first-pass trapping in the pulmonary vasculature, cells placed within well-perfused muscle tissue remain locally viable over a longer window and steadily secrete immunomodulatory cytokines, neurotrophic factors, and exosomes into the circulation. This gradual 'depot effect' aims to prolong anti-inflammatory and neuro-supportive signaling as your immune and nervous systems recover. We clearly distinguish this biological depot rationale from established clinical trial proof of pharmacokinetic superiority.
Role in your protocolOur medical team determines the exact Wharton's jelly MSC and exosome combination, dosage, and administration route after evaluating your medical history and reports.
What we aim to achieve
Therapeutic objectives and functional outcomes we track
Before treatment in Istanbul, our physicians establish your clinical baseline and define realistic biological and functional objectives to track during follow-up.
- 01
Daily Energy, Stamina & Post-Exertional Recovery
By quieting chronic IL-6 and TNF-alpha cytokine activity and supporting mitochondrial bioenergetics, our protocol aims to help lift deep post-infectious exhaustion and improve restorative sleep.
- 02
Joint, Tendon & Muscular Comfort
Shifting synovial and connective-tissue macrophages from destructive M1 to reparative M2 phenotypes helps ease migratory joint aches, morning stiffness, and muscle tenderness during daily movement.
- 03
Peripheral Nerve Soothing & Autonomic Balance
Delivering neurotrophic factors (BDNF, NGF) and anti-inflammatory exosomes to stressed peripheral nerves aims to calm tingling, burning paresthesias, and autonomic sensitivity.
- 04
Cognitive Clarity & Mental Stamina
Calming low-grade neuro-glial inflammation via blood-brain-barrier-permeable WJ-MSC exosomes supports clearer focus, memory recall, and relief from persistent post-Lyme brain fog.
How treatment is personalized
How our medical team evaluates your records and designs your protocol
Our Istanbul medical team led by Uzm. Dr. Cihan Bolat evaluates your post-treatment Lyme history, inflammatory markers, and symptoms to design an individualized Wharton's jelly MSC and exosome protocol.
Medical history & reports we request
- Summary of original Lyme disease diagnosis, serology reports, and symptom timeline
- Documentation of completed antibiotic courses prescribed by your home physician
- Current symptom profile covering fatigue, joint pain, neuropathy, and cognitive clarity
- Recent laboratory panel including CBC, CRP, ESR, liver/kidney function, and thyroid/vitamin levels
- Any neurological (EMG/MRI) or rheumatological evaluations performed to date
Clinical suitability & protocol checks
- Any active, untreated bacterial infection must be treated with appropriate antibiotics by your local physician before considering a regenerative immunomodulatory protocol.
- Patients continue their supportive medications and nutritional regimens as guided by their home care team.
- Your Istanbul treatment plan includes structured 1, 3, and 6-month remote follow-up reviews with our medical team to track your functional recovery.
What the patient journey looks like
From your first inquiry to individualized treatment in Istanbul
- 01
Contact us & share your medical reports
Reach out regarding your condition and share your medical history, diagnosis, imaging, and relevant lab reports via our secure form or WhatsApp.
- 02
Medical team evaluation & protocol design
Our medical team evaluates your records and, where clinically appropriate, develops an individualized Wharton's jelly MSC and exosome protocol.
- 03
Transparent explanation of protocol & costs
We explain the proposed treatment, specific biologics, administration routes, intended therapeutic objectives, stay timeline, and itemized costs.
- 04
Arrange treatment in Istanbul & follow-up
Review your individualized proposal, schedule your visit to Istanbul with private airport and clinic transfers, and continue with structured 1, 3, and 6-month follow-up.
2026 cost & protocol planning
Transparent Istanbul pricing tailored to your protocol
After our medical team evaluates your records, we provide a written proposal explaining the recommended Wharton's jelly MSC and exosome preparations, administration routes, intended objectives, stay timeline, and itemized costs.
For 2026 planning context, targeted exosome and local orthopedic protocols typically range from $3,500–$6,500, while comprehensive Wharton's jelly MSC and exosome programs range from $7,000–$18,000. Your exact cost is confirmed after your medical evaluation.
- Any active, untreated bacterial infection must be treated with appropriate antibiotics by your local physician before considering a regenerative immunomodulatory protocol.
- Patients continue their supportive medications and nutritional regimens as guided by their home care team.
- Your Istanbul treatment plan includes structured 1, 3, and 6-month remote follow-up reviews with our medical team to track your functional recovery.
What your written treatment proposal explains
- 01
Which Wharton's jelly MSC, exosome, or combined protocol is proposed for your condition?
- 02
Which administration routes are recommended and how do they work biologically?
- 03
What are the intended therapeutic objectives and expected stay length in Istanbul?
- 04
What is the itemized cost and how does 1, 3, and 6-month follow-up work after treatment?
Evidence & important considerations
Published clinical research and important considerations
Below is a summary of published human studies, investigated mechanisms, and important limitations relevant to regenerative medicine for this condition.
01 Clinical guidelines on Lyme disease and post-treatment syndrome mechanisms
Open study- Product
- Standard antimicrobial completion followed by supportive immunomodulatory care
- Route
- Systemic intravenous and supportive clinical pathways
- Study design
- Multispecialty clinical guideline and translational neuro-immune research
- Finding
- Clinical guidelines distinguish active Borrelia infection (treated with antibiotics) from persistent post-treatment inflammatory and neuropathic syndromes where immune dysregulation is investigated.
- Limitation
- Mesenchymal stromal cells and exosomes do not possess direct antibacterial activity and are evaluated strictly for post-treatment immunomodulatory and tissue-supportive goals.
Scientific references
Clinical studies and scientific references
FAQ
Frequently asked questions about this treatment
Request Free Medical Evaluation
Begin a personalized treatment conversation with our medical team.
Share your case in confidence. Our international coordinators review every enquiry and respond within 24 hours, in your language.